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Abstract: Evidence suggests that the increased production of free radicals and reactive oxygen 
species lead to cellular aging. One of the consequences is lipid peroxidation generating reactive 
aldehydic products, such as 4-hydroxynonenal (HNE) that modify proteins and form adducts with 
DNA bases. To prevent damage by HNE, it is metabolized. The primary metabolic products are the 
glutathione conjugate (GSH-HNE), the corresponding 4-hydroxynonenoic acid (HNA), and the 
alcohol 1,4-dihydroxynonene (DHN). Since HNE metabolism can potentially change during in 
vitro aging, cell cultures of primary human dermal fibroblasts from several donors were cultured 
until senescence. After different time points up to 30 min of incubation with 5 µM HNE, the 
extracellular medium was analyzed for metabolites via liquid chromatography coupled with 
electrospray ionization mass spectrometry (LC/ESI-MS). The metabolites appeared in the 
extracellular medium 5 min after incubation followed by a time-dependent increase. But, the 
formation of GSH-HNL and GSH-DHN decreased with increasing in vitro age. As a consequence, 
the HNE levels in the cells increase and there is more protein modification observed. Furthermore, 
after 3 h of incubation with 5 µM HNE, younger cells showed less proliferative capacity, while in 
older cells slight increase in the mitotic index was noticed.  
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1. Introduction 
Aging is defined as the accumulation of deleterious changes in cells over time, which increase 
the risk of disease and ultimately lead to death. Over decades, many theories have emerged and 
proven that aging is a multifactorial process. The evolutionary theory of aging considers the 
declining force of natural selection as a cause of aging [1]. The gene regulation theory of aging 
suggests that changes in the expression of certain genes cause aging. This theory is still controversial, 
although many genes exhibit different expression pattern with age [2]. Furthermore, telomere 
shortening and aging are closely related because the length of telomeres decreases with every cell 
division leading to replicative and cellular senescence [3]. The neuroendocrine theory proposes that 
aging is caused by the failure of neurological and endocrine regulation of cell function [4]. This 
theory and the immune theory of aging are cross-linked through neuropeptides and cytokines that 
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maintain communication between the neuroendocrine and the immune system [5]. The free radical 
theory explains aging as a consequence of cumulative oxidative damage caused by endogenous free 
radicals [6]. This theory has been criticized in the past because there was no experimental support 
that free radicals exist in the living organism. However, after work on electron paramagnetic 
resonance and the identification of the hydroxyl radical, and particularly after the enzyme 
superoxide dismutase (SOD) was discovered, this theory had scientific proof that free radicals can be 
generated endogenously [7,8]. 
Increased production of reactive oxygen species (ROS) in aging is associated with increased 
damage to biomolecules [9]. The accumulation of oxidative damage leads to the emergence of 
various pathophysiological conditions, including age-related neurodegenerative diseases [10,11]. 
ROS cause damage to lipids, leading to their oxidative deterioration and production of 
α,β-unsaturated aldehydes [12,13]. 4-Hydroxynonenal (HNE) is a major breakdown product of 
ω-6-polyunsaturated fatty acids (e.g., linoleic, 18:2 and arachidonic acid, 20:4), and it has been 
reported to be a cytotoxic and genotoxic molecule [14–16]. Unlike free radicals which react only with 
biomolecules in their vicinity due to their short half-life, byproducts of lipid peroxidation are more 
stable and react with target molecules that are far from the place of their origin. As with the other 
reactive species, proteins react with HNE and form adducts eventually impairing protein function. 
Amino and sulphydryl groups of cysteine, histidine, and lysine residues are the most reactive with 
HNE. Nevertheless, protein residues are important for HNE-protein formation and their deleterious 
effects, as well as protein structure and whether targeted amino acids are important for protein 
function. Given that proteins are abundantly present in cells, adduct formation leads to changes of 
the tertiary protein structure, inhibition of enzyme activity, as well as changes in gene regulation 
and cell signaling. Therefore, HNE-protein adducts are good biomarkers for oxidative stress [17]. In 
order to prevent the accumulation of HNE and, consequently, the modification of biomolecules, 
tissue damage, and disease progression, cells develop mechanisms to rapidly metabolize HNE. HNE 
metabolism has been studied in different cell types and the major metabolites found are adducts of 
glutathione (GSH) and HNE (GSH-HNE), and the metabolites generated by the oxidation and 
reduction of the carbonyl group of HNE, resulting in the corresponding 4-hydroxynonenoic acid 
(HNA) and alcohol 1,4-dihyroxynonene (DHN) [18]. Glutathione-S-transferase (GST), especially the 
alpha class GSTA4-4, is very specific towards HNE and catalyzes the formation of GSH-HNE [19]. 
HNA and DHN are the result of HNE oxidation and reduction by aldehyde dehydrogenase (ALDH) 
and alcohol dehydrogenase (ADH), respectively. Additionally, GSH-HNE in the reaction catalyzed 
by ADH and ALDH results in GHS-DHN and GSH-HNA. The latter further undergoes 
intramolecular rearrangement generating the corresponding cyclic lactone (GSH-HNL) [20]. 
HNE metabolism serves as the cell’s secondary antioxidant defense. Therefore, this study 
addressed whether an aging cell loses the ability to metabolize HNE efficiently. This was analyzed 
via the characterization of 4-HNE adducts with glutathione in human dermal fibroblasts, which 
serve as a good model for in vitro aging [21]. The understanding of in vitro aging provides valuable 
information about the aging process in vivo, as well as comprehension of the mechanisms involved 
in various degenerative processes accompanying aging. During the process of in vitro, aging cells 
undergo changes in morphology. The cells in later passages are bigger and their morphology is not 
as homogenous as in the first passages. They become flattened, accumulate debris, and show altered 
gene expression [22]. The time point when a cell becomes senescent and the number of cell 
doublings depends on the cell type, donor age, and genotype [23], for example, a reverse correlation 
between passage number and donor age is described [24]. Replicative or cellular senescence can be 
triggered by telomere shortening, oxidative stress induced DNA damage, chromatin disorder, and 
oncogene induction [25]. Depending on its concentration, HNE affects cell proliferation, 
transformation, and cell death [26]. This study, therefore, also aimed to elaborate whether the cells at 
different passages react differently to sublethal 4-HNE concentrations with respect to cell 
proliferation and apoptosis. 
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2. Materials and Methods 
2.1. Chemicals 
Serum free minimum essential medium (MEM), collagenase ll, dispase ll, and fetal bovine 
serum (FBS) were obtained from Gibco, Vienna, Austria. Penicillin and streptomycin were from 
PAA Laboratories, Pasching, Austria. Trypsin/EDTA was obtained from Lonza via Szabo-Scandic, 
Vienna, Austria. Nonessential amino acids, sodium pyruvate, aspartate, L-serine, and all other 
chemicals for cell culture, unless otherwise specified, were obtained from Sigma-Aldrich, Vienna, 
Austria. Nonfat dry milk was obtained from Bio-Rad laboratories, Herculaes, CA, USA. 
HRP-conjugated secondary antibody (goat anti-mouse IgG) was purchased from Abcam, UK. 
Nitrocellulose membrane was obtained from Thermo Fisher Scientific, Rockford, Illinois, USA. 
Plastic labware was purchased from Greiner, Vienna, Austria. HPLC grade water (18MΩ) was 
produced with a Milli-Q water system (Millipore; Milan; Italy). HPLC grade solvents, trifluoracetic 
acid (TFA), PBS, GSH, and formic acid (FA) were purchased from Sigma-Aldrich, Milan, Italy. 
Cell culture MEM was supplemented with 0.2 mM aspartate, 0.2 mM serine, 10 mM pyruvate, 
10% FBS, and 1% penicillin-streptomycin (100 U/mL). 
2.2. Cell Culture 
Fibroblasts were isolated by enzymatic tissue dissociation from foreskins of four healthy male 
donors. The tissue samples were obtained from Paracelsus Medical University Clinics Salzburg, and 
tissue collection was approved by the Ethics Committee of the University of Salzburg (ref. no. 
415-EP/73/548-2015). Initially, tissues were washed in 70% ethanol and rinsed with PBS. The tissues 
were minced into small pieces and incubated overnight at 4 °C with a few ml of dispase II (2.24 
U/mL) solution, diluted 1:1 in PBS followed by additional two to four hours incubation in a cell 
culture incubator at 37 °C, 95% relative humidity, and 5% CO2. Dispase ll enables separation of the 
dermis from the epidermal layer. The dermal layer was incubated overnight with collagenase II (100 
U/mL), diluted in PBS and, then, suspended by gentle shaking. The suspension was filtered through 
a sterile nylon filter (40 µm mesh width) and the filter was washed with MEM. The cell suspension 
was centrifuged at 1000 rpm for 10 min, the supernatant was discarded, and the cells were 
resuspended in complete medium. Cells were seeded into a T-75 cell culture flask and maintained 
and grown to confluence in the incubator with a medium change every third day. When cells were 
approximately 80% confluent, the cells were detached with 0.25% trypsin-EDTA and passaged 
(splitting ratio 1:3). 
2.3. Western Blot Analysis 
At every sixth passage, 1 × 106 fibroblasts were harvested, centrifuged for 10 min at 1000 rpm, 
and lysed with ice-cold cell lysis buffer (50 mM Tris-HCl (pH 8), 150 mM NaCl, 1% Triton X-100, 1 
mM EDTA) in the presence of protease inhibitor cocktail (Roche). The lysate was refined by 
centrifugation for 15 min at 14,000 rpm, at 4 °C and the supernatants were used for the protein 
concentration quantification by using the Bradford assay [27]. Then, 40 µg of proteins, diluted in 4× 
Laemmli sample buffer (Bio-Rad), for each pocket of the gel were separated by sodium dodecyl 
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) using stacking (4%, pH 6.8) and resolving 
gel (12%, pH 8.8). Thereafter, proteins were electro-transferred to a nitrocellulose membrane. To 
prevent nonspecific binding of the antibody to the membrane, the membrane was blocked with 
blocking buffer (5% nonfat dry milk diluted in tris-buffered saline Tween 20 (TBST)). Protein 
immunodetection was performed using primary mouse-anti-HNE-his monoclonal antibody 
(developed in the Koji Uchida’s lab, Tokyo University, Tokyo, Japan) diluted 1:2000 and 
HRP-conjugated secondary goat-anti-mouse antibody diluted 1:10000 in blocking buffer. Proteins 
were detected by chemiluminescence detection system (FUSION, Vilber Lourmat, Eberhardzell, 
Germany). Obtained images and band densities were analyzed by the software provided with the 
FUSION detection system. 
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2.4. Incubation with HNE 
First, 1 × 106 cells were plated in a 60 mm diameter Petri dish with serum-free MEM and 
incubated with 5 µM HNE for 3 h in a cell culture incubator at 37 °C, 95% relative humidity, and 5% 
CO2. After incubation under standard culture conditions, cells were left to grow for an additional 24 
h in a medium with 10% FBS. The second Petri dish was incubated under the same conditions and 
served as control. The experiment was run in two experimental replicates. For mitotic and apoptotic 
index determination, cells were fixed with 5 mL methanol/glacial acetic acid (3:1) for 15 min 
followed by washing with distilled water for 2 min and air drying. The fixed cells were washed with 
McIlvaine buffer (0.2 M Na2HPO4, 0.1 M citric acid, pH 7) and stained with a 
4’,6-diamidino-2-phenylindole (DAPI) solution (0.2 µg/mL) for 1 h, in the dark. After incubation 
with DAPI, cells were washed again with McIlvain and, briefly, with distilled water and left to dry. 
Stained cells were covered with glycerol and a thousand cells per dish were analyzed under the 
fluorescence microscope (Leitz, Aristoplan) to determine the number of mitotic and apoptotic cells. 
The assessment was based on the morphology of stained nuclei (mitotic cells in different stages of 
mitosis, and apoptotic cells with condensed and fragmented nucleus) (Figure 1). 
 
Figure 1. Cell proliferation and apoptosis, cells were stained with 4’,6-diamidino-2-phenylindole 
(DAPI) and pictures were taken under fluorescence microscope. Arrows represent the cell in the state 
of (A) Prophase; (B) prophase and metaphase; (C) early apoptosis; (D) late apoptosis. 
At every third passage, fibroblasts were trypsinized and counted using a hemocytometer. Then, 
1 × 106 cells were plated in a 60 mm diameter Petri dish with MEM containing 10% FBS and 1% 
antibiotics. After attachment, cells were washed twice with pre-warmed PBS which had been 
replaced by serum-free MEM, and 100 µL were taken as a control sample and, then, challenged with 
5 µM HNE for 30 min. The HNE was prepared from 4-hydroxynonenal-diethylacetate (HNE-DEA) 
by hydrolysis with 1 mM HCl, 1 h at room temperature, and calculated from the absorption at λmax 
224 nm and the molar extinction coefficient ε = 13750 L mol−1 cm−1. During the 30 min of HNE 
treatment, 100 µL of medium each were taken at different time intervals (15 s, 1, 2, 5, 10, 20, and 30 
min), transferred into cryovials, and stored at –80 °C, until further use to compare the kinetics of 
HNE metabolism in the cells in the earlier and later passages of cell culture by using liquid 
chromatography coupled with electrospray ionization mass spectrometry (LC/ESI-MS). 
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2.5. Synthesis of the Glutathione-HNE Adduct 
HNE or deuterated HNE (HNEd5) was obtained by hydrolysis of the corresponding 
HNE-dimethylacetal (HNE-DMA) in 1 mM HCl for 1 h at room temperature. HNE-DMA was 
synthetized as reported by Rees and colleagues [28]. Glutathione-HNE and GSH-HNEd5 adducts 
were synthesized mixing glutathione and HNE or HNEd5 2:1 for 3 h at 37 °C, in 10 mM PBS. Adduct 
formation was monitored by HPLC-UV analysis following the chromatographic peak corresponding 
to HNE extrapolated at λmax = 225 nm. Briefly, an aliquot of the reaction was diluted and acidified 
to obtain a final concentration of 40 mM HCl in 90% H2O and 10% ACN. Then, 80 µL of the solution 
were injected by partial loop mode into the platform consisting of a Surveyor HPLC system (Thermo 
Scientific, Rodano, MI, Italy) made up of a MS quaternary pump at a flow rate of 300 µL/min for all 
the experiments. Eluents made up of 1 mM HCl (eluent A) and ACN (eluent B) were used. The 
analyte was separated with a Phenomenex Kinetex C18 column (25 mm × 2.10 mm, 2.6 µm, 100 Å). 
Adducts were stored at −20 °C until use. 
2.6. LC/ESI-MS Analysis 
Before LC-MS analysis, extracellular medium samples were diluted 1:3 with 1% trifluoroacetic 
acid (TFA) and then spiked with the internal standard at a concentration of 1 µM. The samples were 
ready for autosampler injection after centrifugation at 14,000 rpm, for 10 min. The analytical 
platform consisted of an Ultimate 3000 RSLCnano system coupled with an LTQ-Orbitrap XL mass 
spectrometer through a Finnigan IonMax electrospray ionization source (ESI) (Thermo Scientific, 
Rodano, MI, Italy). Ionization was performed in positive ion mode with spray voltage 3.5 kV, 
capillary temperature 220 °C, and capillary voltage 35 kV. During the analysis, the MS spectra were 
acquired in profile mode by Orbitrap using the following settings: Scan range 250 to 700 m/z, 5 × 105 
ions per scan, maximum injection time was set to 500 ms, and resolution was set to 100,000 (FWHM 
at m/z 400). Lock mass option was enabled to provide a real-time internal mass calibration during the 
analysis using a reference list of 20 abundant and known background signals, already reported by 
Keller et al. [29] as common air contaminants in mass spectrometry. Instrument control was 
provided by the software Xcalibur 2.0 and Chromeleon Xpress 6.8 (Thermo Scientific, Rodano, MI, 
Italy). 
First, 15 µL of a sample were loaded, with partial loop injection, on a µ-Precolumn Cartridge 
(PrepMap100 C18, 5 µm, 100 Å, 300 µm i.d. × 5 mm, Dionex) for sample clean up and 
preconcentration for three minutes at a flow rate of 10 µl/min, using 99% mobile phase A (0.1% 
aqueous TFA) and 1% mobile phase B (0.1% HCOOH diluted in acetonitrile). Then, the precolumn 
was diverted online to a Hypersil Gold Capillary Column (C18, 5 µm, 0.18 mm i.d. × 100 mm 175 Å, 
Thermo Fischer Scientific) as an analytical column for metabolite separation. The analytes were 
eluted applying a 30 min ramp gradient using solvents A 0.1% aqueous HCOOH and B 0.1% 
HCOOH diluted in acetonitrile, at a flow rate of 1.5 µL/min. Three minutes after loading, the solvent 
B percentage was increased from 5% to 95% within 18 min and kept constant for four minutes, 
followed by equilibration for five minutes at the initial conditions. The injection was done in partial 
loop mode. The glutathione adducts eluted with a retention time of 14.1 min for glutathione-HNE 
(GSH-HNE) and deuterated GSH-HNE (GSH-dHNE), 13.9 min for glutathione-dihydroxynonene 
(GSH-DHN) and 15.7 min for the corresponding cyclic lactone of glutathione-hydroxynonenoic acid 
(GSH-HNL). 
A calibration curve was prepared by spiking pure medium with adduct solution to give 
concentrations of 0.02, 0.05, 0.25, 0.5, 1, 1.25, 1.5, 1.75, and 2 µM. Three independent samples were 
prepared for each concentration. The calibration curve (Figure 2) was calculated by least square 
linear regression analysis of the nominal concentration of adduct versus adduct/internal standard 
peak area (R2 = 0.9985). The limit of detection (LOD) and limit of quantification (LOQ) were 
determined as 0.02 µM and 0.05 µM, respectively. As an internal standard, deuterated GSH-HNE 
was used at a final concentration of 1 µM. 
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Figure 2. Glutathion and 4-hydroxynonenal (GSH-HNE) calibration curve. 
2.7. Statistical Analysis 
The normality of data distribution was checked applying the Shapiro–Wilks test. For the 
determination of the significance levels for changes of the mitotic and apoptotic index, as well as 
differences in HNE metabolism between passages, Student’s two-tailed t-test for independent 
samples was applied. Analyses were performed using SPSS version 20 (IBM SPSS Statistics) and 
GrpahPad Prism version 8 (GraphPad Software). Results were considered statistically significant 
when the p–value was <0.05.  
3. Results 
By Western blot analysis it was confirmed that aging cells accumulate more HNE-modified 
proteins as compared with the cells on the onset of the cell culture. Taking into account five passages 
(P-24, P-18, P-12, P-6, and last passage) that are common to the fibroblast cell culture of all four 
donors in which protein modification was studied, a constant increase of the amount of 
HNE-modified proteins with increasing number of passages was observed, with statistically 
significant differences between the last passage and the first measurement point, P-24 (Figure 3). 
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Figure 3. Changes of the amount of HNE-modified proteins due to in vitro aging assessed by 
Western blot analysis applying anti-HNE-his monoclonal antibodies. The band intensities were 
quantified by densitometry. LP indicates last passage. Data are presented as mean ± SD of band 
density expressed in percentages. Statistically significant differences are marked with * as compared 
with P-24, with + as compared with P-18, and with ‡ as compared with P-12, for p < 0.05, as analyzed 
by Student’s two-tailed t-test for independent samples (n = 4). 
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To understand the increased rate of HNE-modified proteins, the cells were challenged with 5 
µM HNE for 30 min in order to determine if this is caused by the impaired HNE metabolism. For this 
purpose, 100 µL each of extracellular medium were taken at different time intervals (15 s, 1, 2, 5, 10, 
20, and 30 min) after HNE addition and analyzed by LC/ESI-MS. The metabolism was monitored via 
the formation of two GSH-HNE metabolites, GSH-HNL and GSH-DHN. GSH-HNE, as such, was 
difficult to identify because likely the oxidation and reduction to the corresponding alcohol and acid 
occurred immediately in the cell. By comparing the GSH-HNL kinetics, there was a difference in 
earlier and later passages of cell culture, at the last, and the 12th, and the 21st passages before 
senescence, which are defined as late, middle, and early passages, respectively, GSH-HNL was not 
detectable until five minutes after the addition of the HNE. After five minutes, around 90 nM 
GSH-HNL was detected in the early passage (P-21). After 10 min, four times as much GSH-HNL was 
formed in passage P-21 (~400 nM), while at the last passage an increase in the concentration of only a 
few nM was found. After 20 min of incubation with 5 µM HNE, there was a significant increase of 
the GSH-HNL concentration in passage P-21 (~700 nM) as compared with the last passage (~90 nM). 
Analysis of extracellular medium further demonstrated that a concentration of around 1 µM of 
GSH-HNL could be verified at the early passage and about 200 nM at the last passage after 30 min of 
incubation. These represent 20% and 4% of the initial HNE concentration, respectively (Figure 4). 
 
Figure 4. Comparison of the kinetics of GSH, 4-hydroxynonenoic acid, and lactone 
(GSH-HNA-lactone) formation at early (P-21), middle (P-12), and last passage (LP) in extracellular 
media taken in different time points (0, 15 s, 1 min, 2 min, 5 min, 10 min, 20 min, and 30 min) after the 
addition of HNE. Data are presented as means ± SD (P-21 and P-12 n = 4, LP n = 3). Statistically 
significant differences are marked with * p < 0.05 when P-21 is compared with LP and +p < 0.05 when 
P-21 is compared with P-12 as analyzed by Student’s two-tailed t-test for independent samples. 
The results indicate that the formation of GSH-HNL differs depending on the passage number. 
To obtain a more realistic view on changes of HNE metabolism during in vitro aging, the last 
passage of every donor was taken as the endpoint, from which data were gathered backwards, for 
example, P-3 means three passages backwards. This method of presentation was chosen since the 
donor age differed significantly, from two to 48 years, and would lead to misinterpretations. Figure 
5A clearly shows that the concentrations from the onset of the cell culture to 15 passages before 
senescence is increasing. The highest metabolite concentration after 30 min of incubation was 
around 1 µM, measured 15 passages before senescence, which is about 20% of the initially added 
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HNE concentration. After that point, as from passage 12 before senescence, there is a continuous 
decrease of metabolite formation.  
A further metabolite analyzed, in this study, was GSH-DHN, which is formed by the reduction 
of GSH-HNE by an alcohol dehydrogenase (aldose reductase). GSH-DHN was also found to be 
released from fibroblasts into the extracellular medium in a time-dependent manner. However, a 
smaller amount of this metabolite was formed as compared with the lactone. The highest measured 
concentration, 24 passages before senescence, was ~220 nM, and was followed by a steady decrease. 
On the basis of the measured concentrations of GSH-DHN, it is assumed that less than 5% of the 
amount of HNE added is metabolized via the formation of the GSH-DHN adduct in earlier passages, 
while the concentration found in medium at late passages was not more than 2% (~70 nM) (Figure 
5B). 
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Figure 5. Concentrations of GSH-HNA-lactone (A) and GSH and 1,4-dihydroxynonene (GSH-DHN) 
(B) conjugates measured after 30 min of incubation with 5 µM HNE at different passages of fibroblast 
culture. Data are presented as means ± SD (n = 4). (A) Statistically significant differences are marked 
with * as compared with P-18 and with + as compared with P-15. (B) Statistically significant 
differences are marked with ‡ as compared with P-24, * as compared with P-21, and with + as 
compared with P-15; for p < 0.05, as analyzed by Student’s two-tailed t-test for independent samples. 
Fibroblasts incubated for 3 h with 5 µM HNE were morphologically analyzed, and no 
phenotypical difference could be detected between treated and untreated cells. At the onset of cell 
culture, around 3% of the cells were in M-phase. As expected, the percentage of cells in M-phase 
decreased when cells were approaching the senescent state. Figure 6 shows that proliferation is 
lower in the cells treated with 5 µM HNE relative to untreated cells. This is seen up to six passages 
before senescence was reached, with statistically significant differences at the 18th, 15th, 12th, and 
9th passage before senescence (p < 0.05), after which proliferation was slightly higher in the treated 
cells as compared with the control but not statistically significant. The analysis of apoptotic cell 
death (from a thousand counted cells) revealed that only 0.05% to 0.2% of the cells were in the stage 
of apoptosis. Their number increased slightly when cells were approaching the state of senescence. 
HNE treated cells showed increased levels of apoptosis in almost all passages. However, there is no 
clear indication whether the cells, depending on their age, respond differently to the treatment of 
HNE. Interestingly, at the beginning of cell culture, a significantly larger number of apoptotic cells 
were observed in the HNE-treated cells as compared with the controls. 
 
Figure 6. Influence of HNE treatment on fibroblast cell proliferation at different passages of cell 
culture. Data are presented as means ± SD of the percentage of mitotic cells in culture (n = 4). 
Statistically significant differences are marked with * for p < 0.05 as analyzed by Student’s two-tailed 
t-test for independent samples. 
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4. Discussion 
The focus of this investigation was lipid peroxidation, the most prominent feature of oxidative 
stress. The emphasis was on 4-hydroxynonenal, the major and the most toxic α,β-unsaturated 
aldehyde generated during the oxidative breakdown of polyunsaturated fatty acids. Given that 
HNE affects cell proliferation, transformation, and cell death in a concentration dependent manner 
[15,30,18], the intention was to elaborate whether a sublethal concentration (5 µM) of 4-HNE has an 
impact on the proliferative capacity of fibroblasts during in vitro aging. On the one hand, low 
concentrations of 4-HNE (1 to 2.5 µM) promote cell proliferation as demonstrated in a study of Ruef 
et al. (1998) with rat smooth muscle cells [31]. However, on the other hand, according to Halliwell 
and Gutteridge (2007), HNE concentrations which are achieved in the state of oxidative stress (2 to 
20 µM) are toxic to many cells and inhibit cell proliferation [26]. This was also confirmed with 
cultured Ehrlich ascites tumor cells treated with 10 to 20 µM HNE [32], and even lower 
concentrations of HNE (0.1 µM), that provoked genotoxic effects in rat hepatocytes, as evidenced via 
the analysis of sister chromatid exchanges [33].  
This study revealed that a concentration of 5 µM HNE inhibits cell proliferation up to six 
passages before senescence, but there is a trend towards the induction of cell growth in later 
passages. This could be explainable by the fact that younger cells have mechanisms to neutralize 
added HNE via rapid metabolism and conjugation with glutathione. However, in the cells that 
approach the state of senescence, the metabolic capacity is reduced and the level of free radicals and 
lipid peroxidation products, such as HNE, is already increased causing a reduction of the GSH pool. 
Under these circumstances, increased proliferation reduces the intracellular concentration of both 
HNE and HNE-modified proteins [34]. 
Higher levels of HNE and prolonged oxidative stress exposure compromise cellular functions, 
and eventually lead to cell death. In our study, at all examined passages, except at the last, 5 µM 
HNE caused an increase in the number of apoptotic cells as compared with the non-treated controls, 
but without a clear age dependence. The increased rate of apoptoses upon HNE treatment suggests 
that even sublethal concentrations of HNE induce cell death. Investigations on human retinal 
pigment epithelial cells have proven that HNE causes apoptosis by increasing the expression of the 
tumor suppressor protein 53 [35]. The involvement of the p53 apoptotic pathway has also been 
confirmed in other cell lines, for example, the increased expression of p53 in aging Purkinje cells 
could be the reason for the death of these cells [36,37]. Furthermore, Uchida et al. (1999) reported 
that HNE via the activation of c-Jun N-terminal kinase (JNK) induced c-Jun expression which leads 
to upregulation of proapoptotic AP-1 dependent genes such as FasL [38]. This assumption was 
confirmed in c-Jun deficient mouse fibroblasts which were resistant to cell death accompanied by 
FasL downregulation [39]. However, an earlier publication pointed out that c-Jun deficient mouse 
fibroblasts show a decline of proliferation with elevated levels of p53 [40]. Therefore, additional 
work should be carried out to elaborate the role of HNE in the aging process.  
Previous studies with various cell types have shown that 2% to 8% of cellular proteins are 
modified after the addition of HNE [41]. HNE adduction generates misfolded and damaged proteins 
with impaired function [42], particularly enzymes when HNE reacts with the active site amino acids. 
The content of oxidatively modified proteins has been found to increase in cultured fibroblasts, with 
age above 60 [43]. Therefore, we wanted to analyze the rate of protein HNE modification in human 
skin fibroblast cells undergoing in vitro aging. The results of Western blot analysis, using an 
anti-HNE-his antibody, show that fibroblasts in later passages have more HNE modified proteins as 
compared with early passages, where modified proteins were also detected. Our results are in 
agreement with previous studies on aging embryonic lung and facial skin fibroblasts [44,45] but also 
in keratinocytes [46]. The reason for elevated levels of HNE modified proteins in aging cells could be 
an increase in the rate of HNE production, an impaired antioxidant defence, or impaired HNE 
metabolism, and decrease of proteasome activity [46,47]. HNE as a bifunctional molecule is able to 
form cross-linked proteins, which cannot be degraded by the proteasome. Furthermore, the HNE 
cross-linked proteins are able to inhibit the proteasome [48–5050]. HNE modified proteins, their 
aggregates, and HNE cross-linked proteins are found in many age-related neurodegenerative 
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pathologies, for example, Alzheimer’s disease, Parkinson disease, Huntington disease, and ALS 
[51,52]. Therefore, comprehension of the mechanism of aldehyde adduction to proteins and their 
degradation by cellular repair systems gives us a tool to better understand the pathologies in which 
these modifications are involved. 
The accumulation of modified proteins in aging could be dependent on the intracellular rate of 
HNE metabolism. The enzymatic metabolism of HNE goes through two phases. Phase l includes 
HNE reduction and oxidation resulting in the corresponding alcohol and the carboxylic acid. Phase 
ll is accomplished by Michael addition of GSH to HNE. The GSH-HNE conjugate immediately 
undergoes reduction to GSH-DHN or oxidation to GSH-HNA, which can further form a cyclic 
lactone by intramolecular rearrangement [20]. Therefore, these two metabolites were a further focus 
of this investigation and the following result was obtained: For GSH-HNL, the metabolite levels 
increased up to the 15th passage before senescence followed by a steady and significant decrease. In 
the case of GSH-DHN, the decreasing trend was observed from the beginning of cell culture. This 
behavior of GSH-HNL formation can be explained by an initial adaptation to increasing endogenous 
formation of HNE. The following decrease can be interpreted in terms of a loss of the ability to 
detoxify HNE with an increasing in vitro age. This decline could be due to reduced glutathione 
concentrations observed in aging cells [53] and a consequent decrease in the formation of GSH-HNE 
conjugates. Another reason could be an insufficient GSTA4 activity, the main enzyme for Michael 
addition of GSH to HNE [19]. Nevertheless, whenever the amount of GSH present in the cell is not 
sufficient, even higher expression of GSTA4 is useless. These results, at least in part, explain the 
increased HNE-modified proteins concentrations found in older cells [54]. HNE which is not 
metabolized raises the intracellular HNE pool. Together with the age-dependent increase of the lipid 
peroxidation rate reported [55], this intracellular HNE pool is further increased, thus, enhancing the 
interaction with DNA and proteins.  
The velocity of HNE removal from the cell is not the same in different cell types. The most rapid 
uptake and detoxification have been shown for rat hepatocytes [56], a much slower metabolism in 
synovial fibroblasts [57], human polymorphonuclear lymphocytes [58], or colonocytes [59]. In this 
study, the initially applied HNE amount of 5 µM was not detectable after 1 min in the extracellular 
medium, but GSH-HNL was detected 5 min after HNE addition. In contrast, GSH-DHN was 
detectable in the medium after 30 min of incubation in a much lower amount as compared with 
GSH-HNL. Thus, it is concluded that the oxidation of GSH-HNE is a dominant reaction in the cell. 
RLIP76, a RalA binding protein, is responsible for the transport of GSH-HNE adducts from the cells, 
and it has been shown that RILP76 plays a major role in the regulation of intracellular 4-HNE 
concentration [60]. The higher levels of 4-HNE and GSH-HNE were also observed in RLIP76 
knockout mice, in a radiation toxicology study, proving that this protein is important in cellular 
detoxification [61]. Senescence could theoretically also affect exocytotic activity, however, it is not 
known whether this would also influence RLIP79 based release of GSH-metabolites. In addition to 
these two metabolites, an investigation by Aldini et al. (2003) with human keratinocytes revealed 
S-(4-oxononanal-3-yl)-glutathione, the oxidation product of secondary alcohol on C-4, as one of the 
most abundant metabolites [62]. In the same study it was further shown that more than twice the 
amount of metabolite was still in the cell 30 min after incubation with 100 µM HNE as compared 
with the amount in the extracellular medium and the plateau of formation after 60 min. When these 
findings are extrapolated to our cells, the measured amounts after 30 min would just be half the 
amount of metabolite formed inside the cell. 
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